Search by Drug Name or NDC
NDC 72578-0097-21 tizanidine 4 mg/1 Details
tizanidine 4 mg/1
tizanidine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Viona Pharmaceuticals Inc. The primary component is TIZANIDINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Tizanidine is used to relieve the spasms and increased muscle tone caused by multiple sclerosis (MS, a disease in which the nerves do not function properly and patients may experience weakness, numbness, loss of muscle coordination and problems with vision, speech, and bladder control), stroke, or brain or spinal injury. Tizanidine is in a class of medications called skeletal muscle relaxants. It works by slowing action in the brain and nervous system to allow the muscles to relax.
Related Packages: 72578-0097-21Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Tizanidine
Product Information
| NDC | 72578-0097 |
|---|---|
| Product ID | 72578-097_c1813e2d-81a1-4db6-80a3-12c265d1e8f5 |
| Associated GPIs | |
| GCN Sequence Number | 030274 |
| GCN Sequence Number Description | tizanidine HCl TABLET 4 MG ORAL |
| HIC3 | H6H |
| HIC3 Description | SKELETAL MUSCLE RELAXANTS |
| GCN | 14693 |
| HICL Sequence Number | 011582 |
| HICL Sequence Number Description | TIZANIDINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | tizanidine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | tizanidine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/1 |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Labeler Name | Viona Pharmaceuticals Inc |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208187 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72578-0097-21 (72578009721)
| NDC Package Code | 72578-097-21 |
|---|---|
| Billing NDC | 72578009721 |
| Package | 150 TABLET in 1 BOTTLE (72578-097-21) |
| Marketing Start Date | 2021-03-04 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.04413 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | TIZANIDINE HCL 4 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis